Paul Davies
University of Liverpool(GB)MRC Protein Phosphorylation and Ubiquitylation Unit(GB)
Publications by Year
Research Areas
Migraine and Headache Studies, Prion Diseases and Protein Misfolding, Trace Elements in Health, Ophthalmology and Eye Disorders, Neurological diseases and metabolism
Most-Cited Works
- → Phosphoproteomics reveals that Parkinson's disease kinase LRRK2 regulates a subset of Rab GTPases(2016)1,052 cited
- → A randomized, double-blind, placebo-controlled, parallel-group, enriched-design study of nabiximols* (Sativex®), as add-on therapy, in subjects with refractory spasticity caused by multiple sclerosis(2011)458 cited
- → Characterization of a selective inhibitor of the Parkinson's disease kinase LRRK2(2011)426 cited
- → Randomized controlled trial of cannabis‐based medicine in spasticity caused by multiple sclerosis(2007)380 cited
- → Characterization of VPS34-IN1, a selective inhibitor of Vps34, reveals that the phosphatidylinositol 3-phosphate-binding SGK3 protein kinase is a downstream target of class III phosphoinositide 3-kinase(2014)313 cited
- → A double-blind, randomized, placebo-controlled, parallel-group study of Sativex, in subjects with symptoms of spasticity due to multiple sclerosis